Immunomodulatory effect of Hawthorn extract in an experimental stroke model

Journal of Neuroinflammation

Volumn 7, Issue , 2010, Pages

  Elango, Chinnasamy ^a   Devaraj, Sivasithambaram N ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CRATAEGUS EXTRACT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN BCL XL; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; BCL2L1 PROTEIN, RAT; CYTOKINE; IMMUNOLOGIC FACTOR; NEUROPROTECTIVE AGENT; PEROXIDASE; PLANT EXTRACT; PROTEIN BCL X; STAT3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL INFILTRATION; CELL POPULATION; CONTROLLED STUDY; CRATAEGUS; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOMODULATION; INFLAMMATORY CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; RAT; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; ADULT; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; CHEMISTRY; DISEASE MODEL; ENCEPHALITIS; HISTOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; STROKE;

ADULT; ANIMALS; BCL-X PROTEIN; BRAIN; CRATAEGUS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HUMANS; IMMUNOLOGIC FACTORS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; MALE; NEUROPROTECTIVE AGENTS; PEROXIDASE; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR; STROKE;

EID: 78650605133     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-7-97     Document Type: Article

References (42)

1. Miller ND. Botanical influences on cardiovascular disease. Alter Med Rev 1998, 3:423-430.
2. Elango C, Jayachandaran KS, Niranjali Devaraj S. Hawthorn extractreduces infarct volume and improves neurological score by reducing oxidative stress in rat brain following middle cerebral artery occlusion. Int J Dev Neurosci 2009, 27:799-803. 10.1016/j.ijdevneu.2009.08.008, 19712738.
3. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008, 371:1612-23. 10.1016/S0140-6736(08)60694-7, 18468545.
4. Dirnagl U. Inflammation in stroke: the good, the bad, and the unknown. Ernst Schering Research Found Workshop 2004, 47:87-99.
5. Becker KJ, Kindrick DL, Lester MP, Shea C, Ye ZC. Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. Journal of Cereb Blood Flow Metab 2005, 25:1634-44.
6. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, Vandenbark AA, Hurn PD. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006, 176:6523-31.
7. Vogelgesang A, Grunwald U, Langner S, Jack R, Bröker BM, Kessler C, Dressel A. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008, 39:237-41. 10.1161/STROKEAHA.107.493635, 18048864.
8. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gómez-Choco M, Torres F, Planas AM. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007, 252:29-35. 10.1016/j.jns.2006.10.001, 17129587.
9. Miyake M, Sasaki K, Ide K, Matsukura Y, Shijima K, Fujiwara D. Highly oligomeric procyanidins ameliorate experimental autoimmune encephalomyelitis via suppression of Th1 immunity. J Immunol 2006, 176:5797-804.
10. Chen S, Gong J, Liu F, Mohammed U. Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000, 100:471-80. 10.1046/j.1365-2567.2000.00045.x, 2327042, 10929074.
11. Mao T, Van De Water J, Keen CL, Schmitz HH, Gershwin ME. Cocoa procyanidins and human cytokine transcription and secretion. J Nutr 2000, 130:2093S-9S.
12. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
13. Liao SL, Kao TK, Chen WY, Lin YS, Chen SY, Raung SL, Wu CW, Lu HC, Chen CJ. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett 2004, 372:40-5. 10.1016/j.neulet.2004.09.013, 15531085.
14. Berti R, Williams AJ, Moffett JR, Hale SL, Velarde LC, Elliott PJ, Yao C, Dave JR, Tortella FC. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab 2002, 22:1068-79. 10.1097/00004647-200209000-00004, 12218412.
15. Khan M, Elango C, Ansari MA, Singh I, Singh AK. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem 2007, 102:365-77. 10.1111/j.1471-4159.2007.04526.x, 17437550.
16. Cuenca-López MD, Brea D, Galindo MF, Antón-Martínez D, Sanz MJ, Agulla J, Castillo J, Jordán J. Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation. Rev Neurol 2010, 51:30-40.
17. Jan M, Meng S, Chen NC, Mai J, Wang H, Yang XF. Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics. J Biomed Biotechnol 2010, 2010:459798. 2858284, 20414374.
18. Wang JL, Gu W, Tan F. Effect of erigeron injection on platelet level of CD62p and serum content of TNF-alpha and IL-6 in patients with acute cerebral infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005, 25:324-6.
19. Fu D, Ng YK, Gan P, Ling EA. Permanent occlusion of the middle cerebral artery up regulates expression of cytokines and neuronal nitric oxide synthase in the spinal cord and urinary bladder in the adult rat. Neuroscience 2004, 125:819-31. 10.1016/j.neuroscience.2004.02.012, 15120843.
20. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005, 6:775-86. 10.1038/nrn1765, 16163382.
21. Maier CM, Chan PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002, 8:323-34. 10.1177/107385840200800408, 12194501.
22. Iadecola C, Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94. 10.1097/00019052-200102000-00014, 11176223.
23. Becker K, Kindrick D, McCarron R, Hallenbeck J, Winn R. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size: a role for lymphocytes in ischemic brain injury?. Stroke 2003, 34:1809-15. 10.1161/01.STR.0000078308.77727.EA, 12791945.
24. Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, Hallenbeck JM. Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad of Sci USA 2003, 100:15107-12.
25. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post stroke T helper cell type 1-like immunostimulation. J Exp Med 2003, 1(198):725-36.
26. Wang Q, van Hoecke M, Tang XN, Lee H, Zheng Z, Swanson RA, Yenari MA. Pyruvate protects against experimental stroke via an anti-inflammatory mechanism. Neurobiol Dis 2009, 36:223-31. 10.1016/j.nbd.2009.07.018, 2742567, 19635562.
27. Jiang W, Zhang S, Fu F, Zhu H, Hou J. Inhibition of nuclear factor-kappaB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusion. J Neuroinflammation 2010, 7:55. 10.1186/1742-2094-7-55, 2946287, 20836895.
28. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500. 10.1038/nri2785, 20559327.
29. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-32. 10.1038/nri2343, 2665249, 18566595.
30. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251:189-92. 10.1016/S0304-3940(98)00537-0, 9726375.
31. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005, 5:271-83. 10.1038/nri1589, 15775993.
32. Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006, 212:256-71. 10.1111/j.0105-2896.2006.00423.x, 16903919.
33. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006, 212:28-50. 10.1111/j.0105-2896.2006.00420.x, 16903904.
34. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, Giese T, Veltkamp R. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009, 15:192-9. 10.1038/nm.1927, 19169263.
35. Krasowska A, Konat GW. Vulnerability of brain tissue to inflammatory oxidant, hypochlorous acid. Brain Res 2004, 997:176-84. 10.1016/j.brainres.2003.09.080, 14706870.
36. Springer TA. Adhesion receptors of the immune system. Nature 1990, 346:425-34. 10.1038/346425a0, 1974032.
37. Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002, 33:2115-22. 10.1161/01.STR.0000021902.33129.69, 12154274.
38. Dziennis S, Jia T, Rønnekleiv OK, Hurn PD, Alkayed NJ. Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci 2007, 27:7268-74. 10.1523/JNEUROSCI.1558-07.2007, 2570353, 17611279.
39. Chaitanya GV, Schwaninger M, Alexander JS, Babu PP. Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience 2010, 165:1203-16. 10.1016/j.neuroscience.2009.10.067, 19895873.
40. Rosamond W, Flegal K, Friday G, Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics{NKo letter KA}2007 update: a report from the American Heart Association StatisticsCommittee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-171. 10.1161/CIRCULATIONAHA.106.179918, 17194875.
41. Ovbiagele B. Nationwide trends in in-hospital mortality among patients with stroke. Stroke 2010, 41:1748-54. 10.1161/STROKEAHA.110.585455, 20558829.
42. Pittler MH, Guo R, Ernst E. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 2008, 1:CD005312.